New treatment options for a patient with chronic heart failure and chronic obstructive pulmonary disease
Introduction. The number of patients with chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) is increasing every year. In both CHF and COPD, secondary mitochondrial dysfunction is observed. In this regard, the attention of researchers is attracted by drugs that have thei...
I tiakina i:
| Ngā kaituhi matua: | , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Russo |
| I whakaputaina: |
Remedium Group LLC
2022-04-01
|
| Rangatū: | Медицинский совет |
| Ngā marau: | |
| Urunga tuihono: | https://www.med-sovet.pro/jour/article/view/6805 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|